|Budget: $24.7 million||Financed by: Wild Bunch; Mars Films; Canal+; France 2; M6; Worldview Entertainment|
|Domestic Gross: $42,472||Domestic Distributor: Roadside Attractions|
|Overseas Gross: $2,881,487|
Directed by: Guillaume Canet
Produced by: Hoyt David Morgan
65% of the $24.7 million in financing for Blood Ties was from French sources — Wild Bunch, Mars Films, Canal+, France 2 and M6. Completion finance came from a New York tax credit and $3.5 million from Worldview Entertainment, which would also secure a US distributor. Wild Bunch handled pre-sales and sold out every market except for the US, Spain and Italy. Blood Ties premiered out of competition at Cannes in 2013 and Worldview sold the US rights to Lionsgate and their sister company Roadside Attractions for $2 million. The terms of the sale would give the movie a limited release. This brought the ire of Worldview Entertainment CFO Hoyt David Morgan, who was the largest single investor on the film and he began to question the business practices of the CEO Christopher Woodrow. After the mishandling of Blood Ties, Morgan began to withdraw from the company. One year later Woodrow would be forced out of the company and much litigation followed, with charges of embezzlement and fraud — and he essentially sank Worldview.
Blood Ties received mixed to poor reviews and Roadside Attractions invested very little into the release, which was toplined by the box office contagion Clive Owen. They gave Blood Ties a simultaneous VOD and theatrical rollout. It was booked into 28 theaters and pulled in just $26,912 with a miserable $961 per screen average. It was pulled out of release after two weeks with only $42,472.
Blood Ties was distributed by Mars in France and it performed poorly, grossing $2 million –which comprised the majority of its $2.8 million offshore cume, across numerous distributors. It was dumped in almost every market and went straight to video in Germany and Italy.